Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

NetraMark Holdings Inc C.AIAI

Alternate Symbol(s):  AINMF

NetraMark Holdings Inc. is a Canada-based company, which is focused on the development of Generative Artificial Intelligence (Gen AI)/Machine Learning (ML) solutions targeted at the pharmaceutical industry. The Company’s product offering uses a novel topology-based algorithm that has the ability to parse patient data sets into subsets of people that are strongly related according to several variables simultaneously. This allows the Company to use a variety of ML methods, depending on the character and size of the data, to transform the data into powerfully intelligent data that activates traditional AI/ML methods. The result is that it can work with smaller datasets and accurately segment diseases into different types, as well as accurately classify patients for sensitivity to drugs and/or efficacy of treatment. The typical molecular data used is RNASeq, microarray, single nucleotide polymorphism (SNP) and methylation.


CSE:AIAI - Post by User

Post by waves1on Nov 03, 2021 1:56pm
244 Views
Post# 34083129

Research on $MEND

Research on $MEND

Globally, mental health is a serious issue that needs to be addressed.

  • 78% of adults say the pandemic has been a significant source of stress

  • 264M people are affected by depression globally; it is one of the main causes of disability worldwide

  • 75-85% of people with mental disorders receive no treatment because of stigma, cost, and accessibility.

Nurosene Health Inc. ( $MEND $MEND.c ) is a health technology company focused on providing healthy mind, body, and brain habits to improve daily mental wellness and overall brain health.

Focus on a 4x4 method:

  • 4 therapeutic fundamentals that target 4 different human structures: the spinal cord, peripheral nerve, cerebral cortex, and brain stem

$MEND's mobile application, The Nuro App, provides users with habit-forming strategies and focuses on daily mental health performance

  • Teaches the value of brain health and how it supports physical health -> micro-actions can lead to macro results

  • Focus on sleep, movement, nutrition and mental to assess depression, anxiety, stress, and behavior

Nuro App features:

  1. Activities

  2. Blogs

  3. Journal

  4. Nuro Power Score

The global market size for mobile health applications (mHealth) is expected to reach USD $310 billion by 2027.

  • Benefits that improve lifestyle and treatment outcomes is one of the key factors driving the growth of this market

Comparable valuations:

  1. Calm (meditation, sleep relaxation app) $2B valuation

  2. NOOM (weight loss) $3.7B valuation

  3. Kry (doctor appointments) $2B valuation

$MEND has a highly experienced management team supported by experts with extensive experience in tech, neuroscience, mental health, and capital markets. Plus, it is supported by big names like NFL Star Richard Sherman and Olympian Michael Phelps.
I recently downloaded The Nuro App and can post updates on how I'm liking it!

You can check out $MEND's investor presentation here:

https://cdn.sanity.io/files/18g0k2jo/production/6447b0967d9b200435dc3e248f31fb51ab76b510.pdf

<< Previous
Bullboard Posts
Next >>